Kevin J. Mcnamara - May 2, 2022 Form 4 Insider Report for CHEMED CORP (CHE)

Role
president and CEO, Director
Signature
Kevin J. McNamara
Stock symbol
CHE
Transactions as of
May 2, 2022
Transactions value $
-$5,312,532
Form type
4
Date filed
5/4/2022, 10:33 AM
Previous filing
Mar 9, 2022
Next filing
May 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHE capital stock Sale -$1.46M -3K -2.29% $486.79 128K May 2, 2022 Direct F1
transaction CHE capital stock Options Exercise $3.07M +10K +7.81% $306.70 138K May 2, 2022 Direct
transaction CHE capital stock Tax liability -$3.85M -7.86K -5.7% $489.91 130K May 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHE stock option(right to buy with tandem tax withholding) Options Exercise -$3.07M -10K -5.48% $306.70 172K May 2, 2022 capital stock 10K $306.70 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $479.67 to $496.16. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4.
F2 Payment of purchase price and tax obligation on stock option exercise.
F3 Vesting in three equal annual installments commencing 11/2/2019